Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Equity Ratio (2019 - 2025)

IDEAYA Biosciences' Equity Ratio history spans 7 years, with the latest figure at 0.92 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 2.13% year-over-year to 0.92; the TTM value through Dec 2025 reached 0.92, down 2.13%, while the annual FY2025 figure was 0.92, 2.13% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.92 at IDEAYA Biosciences, roughly flat from 0.92 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.97 in Q1 2024 and bottomed at 0.71 in Q1 2021.
  • The 5-year median for Equity Ratio is 0.92 (2025), against an average of 0.89.
  • The largest YoY upside for Equity Ratio was 22.63% in 2021 against a maximum downside of 21.54% in 2021.
  • A 5-year view of Equity Ratio shows it stood at 0.79 in 2021, then grew by 13.92% to 0.9 in 2022, then grew by 6.2% to 0.96 in 2023, then dropped by 1.5% to 0.94 in 2024, then fell by 2.13% to 0.92 in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Equity Ratio are 0.92 (Q4 2025), 0.92 (Q3 2025), and 0.92 (Q2 2025).